期刊文献+

肽类激素兴奋剂对人体的危害 被引量:3

Damage of peptide hormone doping to human body
原文传递
导出
摘要 兴奋剂是国际体育组织规定的禁用药物和方法的总称,可分为蛋白同化制剂、肽类激素、β2受体激动剂、利尿剂、麻醉剂等不同种类。肽类激素是一类较新的兴奋剂,包括促红细胞生成素、生长激素及胰岛素样生长因子-1、促性腺激素、胰岛素、促皮质激素5大类。肽类激素属于人体内源性物质,很难被检测到,但滥用误用会对人体健康造成损害,如促红细胞生成素可引起过敏反应,生长激素可造成肢端肥大症,胰岛素样生长因子-1可引起急性低磷血症,促性腺激素可造成男性性早熟,胰岛素可造成视物模糊,促皮质激素可造成女性闭经等。 Doping is a generic name of prohibited drugs and methods defined by the International Sport Organization. Doping includes anabolic agents, peptide hormones, β2 receptor agonists, diuretics, narcotics, etc. Peptide hormone is a newer kind of doping, which includes five types : erythropoietin ( EPO ) , human growth hormone (hGH) , insulin-like growth factor-1 ( IGF-1 ) , gonadotrophins, insulin, and corticotrophins. Peptide hormones are endogenous substances of human body, so it is difficult to detect them. However, abuse and misuse of peptide hormone is harmful to human health. For example, EPO may cause anaphylaxis, hGH may cause acromegaly, IGF-1 may cause acute hypophosphatemia, gonadotrophins may cause precocious puberty in male, insulin may cause blurred vision, corticotrophins may cause amenorrhea in female, etc.
作者 王梦然 张健
出处 《药物不良反应杂志》 2008年第2期123-127,共5页 Adverse Drug Reactions Journal
关键词 肽类激素 兴奋剂 危害 peptide hormone doping daniage
  • 相关文献

参考文献17

  • 1Kicman AT, Cowan DA. Peptide hormones and sport:misuse and detection[J]. Br Med Bull, 1992, 48(3) : 496-517.
  • 2中华人民共和国国务院.反兴奋剂条例[S].国务院令第398号.2004-01-03.
  • 3Jelkmann W. Erythropoietin [ J ]. J Endocrinol Invest, 2003, 26(9): 823-827.
  • 4Jelkmann W. Erythropoietin : structure, control of production, and function[J]. Physiol Rev, 1992, 72(2) : 449- 489.
  • 5Gareau R. Erythropoietin abuse in athletes [ J ]. Nature, 1996, 38: 113.
  • 6Audran M, Gareau R, Matecki S, et al. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control [ J ]. Med Sci Sports Exerc, 1999, 31 (5) : 639-645.
  • 7Souillard A, Audran M, Bressolle F, et al. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control[J]. Br J Clin Pharmacol, 1996, 42 (3): 355- 364.
  • 8Abellan R, Ventura R, Pichini S, et al. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse [ J ]. Int J Sports Med, 2006, 28 (1) : 9-15.
  • 9周刚.重组人促红细胞生成素及其检测[J].四川体育科学,2002,21(2):11-12. 被引量:4
  • 10Steinberg H, Saravay SM, Wadhwa N, et al. Erythropoietin and visual hallucinations in patients on dialysis [J]. Psychosomatics, 1996, 37 (6) : 556-563.

二级参考文献14

  • 1吴祖泽.造血细胞研究的进展[J].生理科学进展,1979,(10).
  • 2Parisotto R, et al.Detection of recombinant human erythropoietin abuse in athletes utilizing marks of altered erythropoiesis[J].Haematologica, 2001 Feb, 86(2):128-37.
  • 3Gareau R, Total fibrin and fibrinogen degradation products in urine: a possible probe to detect illicit users of the physical-performance enhance erythropoietin?[J].Horm Res, 1995, 44(4):89-92.
  • 4Parisotto R, et al.Reticlocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes[J].Int J Sports Med, 2000 Oct, 21(7): 471-9.
  • 5Sudran M,et al.Effects of erythropoietin administration in training athletes and possible indirect detection in doping control [J].Med Sci Sports Exerc, 1999, 31: 639-645.
  • 6Birkeland KI, et al.The future of doping control in athletes.Issues related to blood sampling [J].Sports Med, 1999 Jul, 28(1):25-33.
  • 7.Birkeland K, et al.Effect of rhEPO administration on serum levels of StfR and cycling performance[J].Med Sci Sports Exerc, 2000 Jul, 32(7):1238-43.
  • 8Gareau R, et al.Erythropoietin abuse in athletes[J].Nature, 380:113 1996.
  • 9Parisotto R, et al.A novel method utilizing markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes[J].Haemabologica, 2000 Jun, 85(6):564-72.
  • 10Birkeland KI, et al.Blood Samples in Doping Control.First experiences from regular testing in athletics[J].Int J Sports Med, 1997 Jul, 18:8-12

共引文献3

同被引文献41

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部